NASDAQ: INMB
Inmune Bio Inc Stock Ownership - Who owns Inmune Bio?

Insider buying vs selling

Have Inmune Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Scott JudaDirector2026-07-0214,801$1.40
$20.72kBuy
Mark William LowdellChief Scientific Officer2026-07-027,211$1.40
$10.10kBuy
David J. MossChief Executive Officer2026-07-029,014$1.40
$12.62kBuy

1 of 1

INMB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INMB insiders and whales buy or sell their stock.

INMB Shareholders

What type of owners hold Inmune Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Xencor Inc7.09%1,885,533$3.90MInsider
Raymond Joseph Tesi5.85%1,554,106$3.22MInsider
Mark William Lowdell5.71%1,518,017$3.14MInsider
David J. Moss4.87%1,294,883$2.68MInsider
Blackrock Inc4.49%1,194,112$2.47MInstitution
Linda F. Powers3.42%910,000$1.88MInsider
Vanguard Capital Management LLC2.58%687,015$1.42MInstitution
Geode Capital Management LLC1.86%494,969$1.02MInstitution
State Street Corp1.09%290,879$602.12kInstitution
Aqr Capital Management LLC1.02%270,317$559.56kInstitution

1 of 3

INMB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INMB20.23%27.96%Net BuyingNet Buying
BOLD37.78%48.17%Net BuyingNet Buying
XLO7.00%93.00%Net Selling
INKT0.52%99.48%Net BuyingNet Buying
CNTX86.17%1.43%

Inmune Bio Stock Ownership FAQ

Who owns Inmune Bio?

Inmune Bio (NASDAQ: INMB) is owned by 20.23% institutional shareholders, 27.96% Inmune Bio insiders, and 51.81% retail investors. Xencor Inc is the largest individual Inmune Bio shareholder, owning 1.89M shares representing 7.09% of the company. Xencor Inc's Inmune Bio shares are currently valued at $3.90M.

If you're new to stock investing, here's how to buy Inmune Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.